HALIVEN

Swiss trademark · 557354 · Word mark · In force

Register entry

Registration number
557354
Application number
52318/2007
Status
In force
Type
Word mark
Filed
Mar 1, 2007
Registered
Apr 17, 2007
Published
May 1, 2007
Protected until
Mar 1, 2027
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen für die Behandlung von onkologischen Erkrankungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 9, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 09.10.2026

  2. Jun 9, 2026

    Agent removed

    Representative
    A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich (removed)

    Published in Swissreg on 09.06.2026

  3. Jun 9, 2026

    Agent entered

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 09.06.2026

  4. Jan 11, 2017

    Renewed

    Published in Swissreg on 11.01.2017

  5. Apr 16, 2014

    Agent’s address changed

    Representative
    A. W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  6. May 1, 2007

    Registered

    Published in the SOGC no. 83 of 01.05.2007

Parties

Holder

Eisai R&D Management Co., Ltd.

Eisai R&D Management Co., Ltd

6-10, Koishikawa 4-chome Bunkyo-ku, 112-8088 Tokyo, JP

Agent

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.